By upregulating beta‐3‐adrenoceptors in adipose tissue, capsiate may be a viable medication for maximising the anti‐obesity advantages of exercise training, according to Wang et al.53 The gene discussed is ADRB3; the disease is obesity due to melanocortin 4 receptor deficiency.